ClosedPublished 14 May 2025

Aerovate Therapeutics, Inc. /
Jade

Aerovate Therapeutics combines with Jade in completed merger

Buy side: Aerovate Therapeutics, Inc.
Buy sideAerovate Therapeutics, Inc.
Target: Jade
TargetJade
Source · 14 May 2025Source-verified
Buy side: Aerovate Therapeutics, Inc.
Buy sideAerovate Therapeutics, Inc.
Target: Jade
TargetJade
01 / BuyerAerovate Therapeutics, Inc.
02 / TargetJade
Source-verified
01

What happened

Aerovate Therapeutics, Inc. completed its business combination with Jade on April 28, 2025. Jade became a wholly owned subsidiary of Aerovate.

The combined company focuses on developing biologic therapies for patients living with autoimmune diseases.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Aerovate Therapeutics combines with Jade in completed merger

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.